Stratipath

Stratipath Medical is a Swedish startup that aims to revolutionize cancer treatment decisions and outcomes through AI-based precision diagnostics. It is a spin-out of Karolinska Institutet in Stockholm, leveraging state-of-the-art deep learning technologies to provide risk profiling of cancer tumors to healthcare and life science companies. Their cloud-based SaaS solutions have gained traction in clinical settings, following years of ground-breaking research. Founded in 2019, the company has quickly made strides in the Health Care industry, offering precision diagnostics at an affordable cost and within a fraction of the time compared to traditional methods.

The most recent milestone for Stratipath Medical was the kr20.00M Seed Round investment announced on 28 February 2021. This investment signifies a vote of confidence from the investors in the potential of the startup's innovative approach to cancer diagnostics. Although the specific investors for this round are not disclosed, the infusion of capital is expected to fuel the company's growth and further advancement in the field of precision medicine.